A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™).
Gül F, Gonen ZB, Jones OY, Taşlı NP, Zararsız G, Ünal E, Özdarendeli A, Şahin F, Eken A, Yılmaz S, Karakukçu M, Kırbaş OK, Gökdemir NS, Bozkurt BT, Özkul Y, Oktay BD, Uygut MA, Cinel I, Çetin M.
Gül F, et al. Among authors: cetin m.
Front Immunol. 2022 Nov 9;13:963309. doi: 10.3389/fimmu.2022.963309. eCollection 2022.
Front Immunol. 2022.
PMID: 36439138
Free PMC article.